Sexual Dysfunction Associated with the Drug Treatment of Psychiatric Disorders: Incidence and Treatment

CNS Drugs

Volumn 2, Issue 1, 1994, Pages 78-86

  Stein, Dan J ^a   Hollander, Eric ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003322726     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/00023210-199402010-00006     Document Type: Article

References (123)

1. Sexual side effects of antipsychotic medications: evaluation and interventions
2. Antipsychotic drug therapy and sexual dysfunction in men
3. Effects of psychotropic drugs on human erection and ejaculation
4. Role of brain monoamines in male sexual behavior
5. Sexual motivation: a neural and behavioral analysis of the mechanisms underlying appetitive and copulatory responses of male rats
6. Endocrinological changes in patients with sexual dysfunction under longterm neuroleptic treatment
7. Sexual dysfunction and plasma prolactin levels in neuroleptic-treated outpatients
8. A pilot study of a structured interview addressing sexual function in men with schizophrenia
9. The effects of phenothiazines on endocrine function. II: effects in men and post-menopausal women
10. Effects of dopamine blockade on gonadotropins and testosterone in men
11. Calcium channel blockade: possible explanation for thioridazine’s peripheral side effects
12. Genitourinary and sexual adverse effects of psychotropic medication
13. Sexual behavior of the male schizophrenic: the impact of illness and medications
14. Effect of antipsychotic drugs on reproductive functions
15. Sexual dysfunction secondary to Mellaril
16. Clozapine: guidelines for clinical management
17. Thioridazine and sexual dysfunction
18. Spontaneous ejaculations and neuroleptics
19. The inhibition of the motility of human spermatozoa by various pharmacologic agents
20. Effect of psychoactive drugs on the motility of human spermatozoa
21. Schizophrenia, oligospermia, and the phenothiazines
22. Priapism and psychotropic medication
23. Evaluation and treatment of priapism
24. The nerve supply of the erectile cavernous tissue in the genitalia in the human embryo and fetus
25. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence
26. Priapism resulting from fluphenazine hydrochloride reversed by diphenhydramine
27. Penile parkinsonism
28. A long-acting phenothiazine as a possible agent to control deviant sexual behavior
29. The control of deviant sexual behavior by drugs: a double-blind controlled study of benperidol, chlorpromazine, and placebo
30. Therapeutic use of thioridazine in premature ejaculation
31. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias
32. Successful treatment of paraphilic coercive disorder (a rapist) with fluoxetine hydrochloride
33. Tricyclic side effects without tricyclics in depression
34. Nocturnal penile tumescence is diminished in depressed men
35. Antidepressant drug therapy and sexual dysfunction in men: a review
36. Sexual side effects of antidepressant drugs
37. Effect of antidepressant medication on sexual function: a controlled study
38. Sexual dysfunction during antidepressant treatment
39. Effects of antidepressants on genitourinary function
40. Clomipramine (anafranil) in the treatment of premature ejaculation
41. An assessment of clomipramine (anafranil) in the treatment of premature ejaculation
42. Treatment of ejaculatio praecox with monoamine oxidase inhibitors
43. Anorgasmia associated with imipramine but not desipramine: case report
44. Psychoactive drugs and human sexual behavior: the role of serotonergic activity
45. Facilitated sexual behavior reversed and serotonin restored by raphe nuclei transplanted into denervated hypothalamus
46. Reversal of pargyline induced inhibition of sexual behavior in male rats by pchlorophenylalanine
47. Sexual side effects of clomipramine (anafranil)
48. Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial
49. Unusual side effects of clomipramine associated with yawning
50. Fluoxetine-induced sexual dysfunction
51. Anorgasmia with the use of fluoxetine
52. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction
53. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine
54. Fluoxetine-induced sexual dysfunction [letter]
55. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors
56. Overview of sexual dysfunction complicating the treatment of depression
57. Repeated observations of yawning, clitoral engorgement, and orgasm associated with fluoxetine administration
58. Repeated observations of yawning, clitoral engorgement, and orgasm associated with fluoxetine administration [letter]
59. Association of fluoxetine and return of sexual potency in three elderly men
60. Beneficial sexual side-effects from fluoxetine
61. Treatment of impotence with trazodone: a case report
62. Increased libido in women receiving trazodone
63. Increased libido in three men treated with trazodone
64. Trazodone and priapism
65. The aphrodisiac effect of fenfluramine: two case reports of a possible side effect to the use
66. Effects of stereoselective 5-HT-1A agonists on male rat sexual behavior
67. The sexual side effects of antidepressant medication: a double-blind comparison of two antidepressants in a nonpsychiatric population
68. Lithium induced male sexual impairment. Two case reports
69. Sexual function in lithium treated manic depressive patients
70. Lithium: its effect on human spermatozoa, rat testicular tissue and upon rats in vivo
71. Valproate in psychiatric disorders: literature review and clinical guidelines
72. Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder
73. Sexual side-effects of psychiatric drugs
74. Treatment of premature ejaculation with lorazepam [letter]
75. Sexual side effects of alprazolam
76. The effect of single dose diazepam on female sexual response induced by masturbation
77. Beta-blocker effects on sexual function in normal males
78. The effect of atropine, and beta blockers on human penile erection: a controlled pilot study
79. Partial ejaculatory incompetence: the therapeutic effect of midodrine, an orally selective alpha-adrenoceptor agonist
80. Antipsychotic drug side effects: their relationship to dose
81. Sexual dysfunction in women using major tranquillizers
82. Psychotropic induced sexual inhibition
83. Hyperprolactinemia and sexual disorders in men
84. Sexual behavior during L-dopa treatment for Parkinsonism
85. Effect of L-dopa on sexually impotent patents
86. Male diabetic sexual impotence: effects of dopaminergic agents
87. Pergolide therapy in Parkinson’s disease
88. Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects
89. Apomorphine induced penile tumescence in impotent patients - preliminary findings
90. Assessment of erotogenic properties of apomorphine and yohimbine in man
91. Spontaneous remission of MAOI-induced anorgasmia
92. Reversal of doxepin-induced hypoactive sexual desire by substitution of nortriptyline
93. Bupropion: an antidepressant without sexual pathophysiological action
94. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion
95. Pharmacological modification of psychosexual dysfunction
96. Treatment of fluoxetine-induced anorgasmia with amantadine
97. Treatment of tricyclic antidepressant induced orgasmic inhibition with cyproheptadine [letter]
98. Reversal of MAOI-induced anorgasmia with cyproheptadine [letter]
99. Cyproheptadine and antidepressant induced anorgasmia
100. Cyproheptadine for imipramine-induced anorgasmia
101. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients
102. Fluoxetine-induced yawning and anorgasmia reversed by cyproheptadine treatment [letter]
103. Reversal of antidepressant activity of fluoxetine by cyproheptadine
104. Effects of serotonin antagonists in sexually impotent men
105. Effect of atropine and methylatropine on human vaginal blood flow, sexual arousal and climax
106. Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants
107. Bethanechol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: case report
108. Reversal by bethanechol of imipramine-induced ejaculatory dysfunction [letter]
109. Antidepressant induced sexual dysfunction in men: due to cholinergic blockade?
110. Enhancement of sexual motivation in male rats by yohimbine
111. Double-blind trial of yohimbine in treatment of psychogenic impotence
112. Is yohimbine effective in the treatment of organic impotence? Results from a controlled trial
113. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study
114. The role of yohimbine for the treatment of erectile impotence
115. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers
116. Inhibited female orgasm resulting from psychotropic drugs. A five-year, updated, clinical review
117. The use of nortriptyline hydrochloride in urology
118. Imipramine for aspermia after lymphadenectomy
119. Sexual effects of antidepressants and psychomotor stimulant drugs
120. Pharmacosexology: the effects of drugs on sexual function: a review
121. Approaches to the development of oral drug therapies for erectile dysfunction
122. Prosexual drugs: empirical status of the ‘new aphrodisiacs’